Soarin' Eagle

SHAREHOLDER ALERT: Morris Kandinov Investigating DNA, APA, LDI and BFLY; Shareholders are Encouraged to Contact the Firm

Retrieved on: 
Wednesday, February 1, 2023
Permian, Complaint, Advertising, NYSE, LoanDepot, Central District, APA, Sale, Butterfly network, Register, APA Corporation, IPO, SAN, District court, Registration statement, Growth, Soarin' Eagle, Insurance, Security (finance), Ginkgo

Morris Kandinov is investigating Ginkgo Bioworks Holdings, Inc. regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders.

Key Points: 
  • Morris Kandinov is investigating Ginkgo Bioworks Holdings, Inc. regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders.
  • On May 2, 2022, an amended complaint was filed and on July 18, 2022, a second amended complaint was filed.
  • Morris Kandinov is investigating Butterfly Network, Inc. regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders.
  • Concerned shareholders are encouraged to contact Leo Kandinov to learn more:
    Morris Kandinov LLP is a national law firm that specializes in recovering investment losses and protecting stockholder rights.

Prairie Band Casino & Resort and Soaring Eagle Gaming Are Latest Tribes to Join the Bingo Treasures™ Network

Retrieved on: 
Thursday, December 22, 2022
Diamond, Parlay, Soarin' Eagle, Partnership, Commercial, Saginaw Chippewa Tribal Nation, Jamul Casino, Business, Charity (practice), Prairie Band Casino & Resort, PlayNow.com, Soaring Eagle Casino & Resort, NE, Bingo, Golf, II, Kia Rio, Tribe, Gambling, Eagle Games, Class

OMAHA, Neb., Dec. 22, 2022 (GLOBE NEWSWIRE) -- VKGS LLC ("Video King") is pleased to announce today the completion of two additional Managed Services Agreements with Prairie Band Casino & Resort ( www.prairieband.com ) and Soaring Eagle Gaming ( www.soaringeaglecasino.com ) for Bingo TreasuresTM.

Key Points: 
  • OMAHA, Neb., Dec. 22, 2022 (GLOBE NEWSWIRE) -- VKGS LLC ("Video King") is pleased to announce today the completion of two additional Managed Services Agreements with Prairie Band Casino & Resort ( www.prairieband.com ) and Soaring Eagle Gaming ( www.soaringeaglecasino.com ) for Bingo TreasuresTM.
  • Prairie Band Casino & Resort, is a premier Kansas casino destination, including fabulous accommodations, entertainment, spa, golf and gaming located in Mayetta, Kansas; and Soaring Eagle Gaming owner and operator of Soaring Eagle Casino & Resort, located in Mt.
  • Prairie Band and Soaring Eagle Casino & Resort are the latest tribal gaming enterprises to join Jamul Casino, as founding participants in the Bingo Treasures Network.
  • Tim Stuart, President & CEO commented that he is "delighted that Soaring Eagle and Prairie Band, two long-term customers of our core bingo business, see the value of becoming a part of the Bingo Treasures network and have decided to join Jamul Casino as founding members.

Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals

Retrieved on: 
Friday, November 11, 2022
CEO, K-12, Agriculture, Program, UC, COVID-19 testing, University of California, Berkeley, Risk, U.S. Securities and Exchange Commission, History of Istanbul, Doctor of Philosophy, Technology, Research, Solution, Metabolic engineering, Food, Acquisition, Soarin' Eagle, SEC, San Francisco Bay Area, Chemistry, Forward-looking statement, Ginkgo Bioworks, Computer, Biotechnology, DNA, Therapy, COVID-19, Partnership, NYSE, Synthetic biology, Fine chemical, Risk management, Ginkgo

BERKELEY, Calif. and BOSTON, Nov. 11, 2022 /PRNewswire/ -- Lygos, Inc., a vertically integrated provider of sustainable specialty ingredients, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a multi-product research and development collaboration designed to optimize and scale production of sustainable specialty ingredients that can replace toxic petrochemistry, reclaim local manufacturing, and advance industrial bio-innovation.

Key Points: 
  • Under the terms of the deal, Lygos and Ginkgo plan to advance two research and development programs over the course of approximately two years.
  • Lygos' organic acid targets are used to produce biodegradable formulations and polymer-based products used in consumer, agricultural, and industrial markets.
  • "Many specialty organic acids rely on environmentally damaging and costly production processes.
  • We're excited to be working with Lygos to replace some of those harmful production methods with sustainable, environmentally friendly biomanufacturing processes," said Ena Cratsenburg, Chief Business Officer at Ginkgo Bioworks.

Melinda Coffin, CEO, Soaring Eagle Casino & Resort, "We are excited to begin using Quick Custom Intelligence's Unified Gaming Platform."

Retrieved on: 
Wednesday, November 2, 2022
Marketing, Soaring Eagle Casino & Resort, CEO, Automation, Robotic process automation, Partnership, Saginaw Chippewa Tribal Nation, Time, Soarin' Eagle, QCI, Eagle, View, Unified, Technology, Cyber Quest, Jacuzzi, VIP, SAN, Casino

The Unified Gaming Platform aligns marketing, player development, and casino operations around one view of the casino's data.

Key Points: 
  • The Unified Gaming Platform aligns marketing, player development, and casino operations around one view of the casino's data.
  • "The team at Soaring Eagle Casino & Resort is very excited to begin using the QCI Platform.
  • To top it all off, their Robotic Process Automation will save us time and money each month accurately loading our marketing offers," commented Melinda Coffin, Chief Executive Officer, Soaring Eagle Casino & Resort.
  • We see our business partnership with Soaring Eagle, a premier operator in the Michigan market, as a strategic business relationship.

Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health

Retrieved on: 
Tuesday, October 25, 2022
U.S. Securities and Exchange Commission, K-12, Computer, SEC, Therapy, Risk, General manager, Agriculture, MISA, Livestock, COVID-19 testing, Concentric objects, Ministry of Investment (Saudi Arabia), NYSE, Biotechnology, Synthetic biology, Program, Partnership, Technology, Acquisition, Biosecurity, Ecosystem, Soarin' Eagle, Ginkgo Bioworks, Food, Forward-looking statement, DNA, Kingdom, Environmental health, COVID-19, Data analysis, Human, Public health, Pharmaceutical industry, Vaccine, Risk management, Ginkgo

BOSTON and RIYADH, Saudi Arabia, Oct. 25, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and the Ministry of Investment of Saudi Arabia ("MISA"), representing the Kingdom of Saudi Arabia, today announced that they have entered into a non-binding Memorandum of Understanding with the intent of developing biotechnology and biosecurity capabilities to deploy new public health initiatives in the Kingdom of Saudi Arabia. 

Key Points: 
  • MISA is tasked with developing the cross-government investment ecosystem in the Kingdom of Saudi Arabia, including biotechnology and biosecurity capabilities.
  • Ginkgo, in partnership with MISA and other institutions, will support and partner in the development of such capabilities.
  • "Biotechnology holds incredible potential to deliver benefits to human and environmental health as well as global health security.
  • "We are pleased to work with the Ministry of Investment as they work to expand these critical capabilities within the Kingdom of Saudi Arabia to address domestic and global biosecurity challenges."

Bolt Threads Announces Latest Collaboration with Ginkgo Bioworks to Optimize its Mylo™ Material

Retrieved on: 
Thursday, October 20, 2022
U.S. Securities and Exchange Commission, Color, Hypergymnasia, K-12, Computer, SEC, Therapy, Risk, Efficiency, Agriculture, COVID-19 testing, NYSE, Biotechnology, Synthetic biology, Fungus, Program, Entrepreneurship, Partnership, Technology, Textile, Mycelium, Acquisition, Industry, Bolt, CEO, Soarin' Eagle, Protein, Food, Forward-looking statement, DNA, Fast Company, Adidas, COVID-19, Solution, Livestock, Fur clothing, Risk management, Kering, Ginkgo, Codebase

BOSTON, Oct. 20, 2022 /PRNewswire/ -- Bolt Threads, a biotechnology company creating the next generation of advanced materials, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a multi-project collaboration to increase the production efficiency and performance of Bolt's current portfolio as well as expand it by developing novel proteins for biomaterials. The first program in this collaboration aims to optimize the production efficiency of Bolt's Mylo™ material, a leather alternative made out of mycelium, the underground root-like system of fungi.

Key Points: 
  • The first program in this collaboration aims to optimize the production efficiency of Bolt's Mylo material, a leather alternative made out of mycelium, the underground root-like system of fungi.
  • Through this collaboration, Ginkgo aims to increase the growth rate of Bolt's mycelium, lowering the overall production costs of Mylo.
  • This collaboration also marks an expansion of the companies' work together, as they are already working to optimize the sustainability, efficiency and cost effectiveness of Bolt Threads' b-silkprotein manufacturing process.
  • Bolt Threads is at the forefront of this shift, and Mylo represents this future," said Jason Kelly, CEO and co-founder, Ginkgo Bioworks.

IARPA, Ginkgo Bioworks and Draper Announce New Technologies to Detect Engineered DNA

Retrieved on: 
Monday, October 17, 2022
Method, U.S. Securities and Exchange Commission, K-12, Computer, SEC, Government, Therapy, Risk, Intelligence Advanced Research Projects Activity, Agriculture, Science, YouTube, COVID-19 testing, Intelligence community, NYSE, Biotechnology, Synthetic biology, Biology, Gene editing, Genetic engineering, Research, Program, Intelligence, Partnership, Senior, Technology, Technical, IARPA, Software, Australian Intelligence Community, Acquisition, Industry, NGS, Health, CEO, Soarin' Eagle, Ginkgo Bioworks, Food, Environment, Forward-looking statement, DNA, Environmental monitoring, COVID-19, Solution, Engineering, Risk management, Television, Ginkgo, Draper, Design

Specifically, Ginkgo has developed a suite of new computational tools and Draper has developed a new experimental platform to help detect and identify when samples include genetically engineered biological systems.

Key Points: 
  • Specifically, Ginkgo has developed a suite of new computational tools and Draper has developed a new experimental platform to help detect and identify when samples include genetically engineered biological systems.
  • This software aims to make it possible for scientists to detect engineered DNA at scale.
  • "Through their work on the FELIX program, Ginkgo and Draper have achieved two major breakthroughs for the biodetection community," said David A. Markowitz, Program Manager at IARPA.
  • We care deeply about securing that vision by ensuring that biology is engineered and deployed responsibly," said Jason Kelly, CEO and co-founder, Ginkgo Bioworks.

Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency for Health

Retrieved on: 
Monday, September 12, 2022
Risk, Health, Therapy, Agriculture, Alexander von Humboldt Foundation, Biological Technologies Office (DARPA), COVID-19, Gene editing, NYSE, Infection, Center, U.S. Securities and Exchange Commission, BTO, Alexander von Humboldt, ARPA, Computer, DARPA, Face, Acquisition, K-12, Soarin' Eagle, Synthetic biology, Program, Business, Forward-looking statement, Georgia Institute of Technology College of Computing, Cancer, Technology, BS, General manager, Doctor of Philosophy, Food, Ginkgo Bioworks, White House, Research, DNA, Biotechnology, COVID-19 testing, SEC, Business development, Disease, Biology, Management, Pharmaceutical industry, Biosecurity, Ginkgo

BOSTON, Sept. 12, 2022 /PRNewswire/ -- The White House today announced that President Biden intends to appoint Renee Wegrzyn, PhD, as the first Director of the Advanced Research Projects Agency for Health ( ARPA-H ).

Key Points: 
  • BOSTON, Sept. 12, 2022 /PRNewswire/ -- The White House today announced that President Biden intends to appoint Renee Wegrzyn, PhD, as the first Director of the Advanced Research Projects Agency for Health ( ARPA-H ).
  • Dr. Wegrzyn is currently the Vice President for Business Development at Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming.
  • ARPA-H was established in March 2022 to drive transformative health breakthroughs that cannot readily be accomplished through traditional research or commercial activity.
  • "Some of the problems we face every day - especially in health and disease - are so large they can seem insurmountable.

Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools

Retrieved on: 
Thursday, September 1, 2022
Enzyme, University, COVID-19, Food, Technology, Synthetic biology, CEO, NYSE, Program, Business administration, Agriculture, Biogen, Computer, Risk, Novo Nordisk, Persephone, DNA, Forward-looking statement, SEC, Lonza, Sherbrooke, Genetic engineering, U.S. Securities and Exchange Commission, Catalent, Metabolic engineering, Roche, MBA, Ginkgo Bioworks, COVID-19 testing, Biotechnology, Therapy, Soarin' Eagle, Acquisition, Industry, Life, Patient, K-12, Fine chemical, Ginkgo, Chemistry, AbbVie

BOSTON, Sept. 1, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that Behzad Mahdavi, Ph.D., MBA, has joined as senior vice president of biopharma manufacturing and life sciences tools.

Key Points: 
  • BOSTON, Sept. 1, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that Behzad Mahdavi, Ph.D., MBA, has joined as senior vice president of biopharma manufacturing and life sciences tools.
  • Ginkgo has significant experience in the design of custom organisms and the discovery of novel enzymes that bring new biopharma products to life.
  • "Ginkgo is integrating capabilities at massive scale in genetic engineering, manufacturing process optimization and bioinformatics along with innovative technologies from third-party developers," said Dr. Mahdavi.
  • To discuss how you can leverage Ginkgo's biopharma and life science capabilities, s ign up for Ginkgo Office Hours to speak with our team today!

Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Assets

Retrieved on: 
Friday, August 19, 2022
Epidemic, Soarin' Eagle, U.S. Securities and Exchange Commission, Public health, Computer, Risk, Synthetic biology, CEO, Forward-looking statement, NYSE, Technology, Biosecurity, SEC, Database, Concentric objects, Agriculture, Infection, K-12, General manager, DNA, COVID-19, School, Food, Acquisition, Program, Therapy, Vaccine, Biotechnology, Pandemic, Private sector, Forecasting, Airport, COVID-19 testing, Risk management, Ginkgo

BOSTON, Aug. 19, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the purchase of certain epidemiological data infrastructure assets from Baktus, Inc., a Delaware-based public benefit corporation. Under the terms of the deal, Ginkgo will assume ownership of proprietary datasets, modeling and analytic tools, and a software platform with the capabilities to track, model, and forecast epidemics and associated risks and impacts. Ginkgo also expects to integrate several ongoing epidemiological analysis projects and a team of epidemiological data experts into its biosecurity and public health initiative, Concentric by Ginkgo.

Key Points: 
  • Ginkgo also expects to integrate several ongoing epidemiological analysis projects and a team of epidemiological data experts into its biosecurity and public health initiative, Concentric by Ginkgo.
  • In addition to epidemiological tracking and forecasting, the company created specialized data infrastructure to help governments and other partners understand and model the risks and disruptive impacts of pathogens in order to promote resilience to pandemics and epidemics.
  • Baktus and Metabiota are expected to continue their independent operations after transferring the assets and epidemiological data personnel included in this transaction.
  • "Ginkgo's biosecurity initiative is an ideal home for our data, analytics, and expertise, and we are very excited to join the Ginkgo team."